PHARMAC is pleased to announce the listing of intravenous nicardipine in Part II of Section H of the Pharmaceutical Schedule from 1 June 2015.

From 1 June 2015 nicardipine hydrochloride injection (2.5 mg per ml, 10 ml vial) will be:

• listed in Part II of Section H of the Pharmaceutical Schedule; and
• restricted to the following classes of prescribers - anaesthetist, intensivist and paediatric cardiologist.

For more details, go to: http://www.pharmac.health.nz/news/notification-2015-05-11-intravenous-nicardipine/